Biotechnology

The biotech industry comprises bio-pharma, bio-services, bio-agri, bio-industrials and bioinformatics. Biopharma is a rapidly growing segment that accounts for a dominant share of this sector. Advancements in biotechnology has enabled researchers to evaluate and identify target biomarkers/cell receptors to develop targeted and personalized therapies. Increasing scientific understanding, advanced tools and techniques has led to emergence of various personalized medicines that are now in research phase. According to a research conducted by Personalized Medicine Coalition, 42% of all compounds and 73% of oncology compounds in the pipeline possess the potential to be personalized medicine. Moreover, according to this study, it is expected that companies will increase their investment in R&D of personalized medicines by 1/3rd over the following five years. The study found that over 20% of drugs approved in 2014 were personalized medicines.

Biotech sector has witnessed some disruptive innovations such as gene and cell therapies, immunotherapy, and antibody drug conjugates. Advancement in stem cell therapy is resulting in effective treatment therapies for chronic conditions, organ growth and repair and also in disease prevention.

Key Challenges

Biotech products have extensive usage in oncology and autoimmune disease treatments. However, the costs of these drugs are exorbitantly high owing to extensive research and trials that need to be carried out for the same. Therefore, there is constant pressure to reduce price and increase accessibility, especially in emerging economies. In the U.S., companies are facing reimbursement issues with respect to biopharmaceutical products. Besides, there are regulatory and scientific challenges faced by the sector. Scientific research for new molecules and targeted therapies is capital intensive and challenging, with increased concern for safety of the drug.

Also, there is lack of awareness about personalized medicine among most healthcare providers, which hinders its adoption. Clinical adoption of the biotech products is essential for its success. However, it entails a lot of scientific evidences and explanation to the prescribers in order to ensure its safety.

“Translating genomic discoveries into personalized medicines entails overcoming substantial scientific, regulatory, and economic challenges, including identifying validated biomarkers, as well as developing personalized therapeutics and clinically relevant diagnostic tests.”

  • Tufts Center for the Study of Drug Development

Opportunities

The biopharmaceutical sector offers vast lucrative growth opportunities. High efficacy and safety of biopharmaceutical products has led to increased demand for the same, with consumers willing to pay high prices for these as compared to other conventional products. Moreover, biopharmaceutical brands have set new standards for blockbuster drugs by recording an annual average sales of over US$ 2 Bn. Certain drugs such as Humira have generated sales of over US$ 10 Bn. Thus, investing in biotech R&D has yielded better results than pharmaceutical drugs.

For generic players, biosimilars offers a very good growth opportunity, as governments in emerging economies are supporting such therapies as cost-effective alternatives to biotech products. Therefore, cost-effectiveness and high quality are prime parameters that need to be considered while developing biosimilars. Recent and upcoming biologic patent expirations include the following:

  • Erbitux (cetuximab) - February 2016
  • Rituxan (rituximab) - September 2016
  • Herceptin (trastuzumab) - June 2019
  • Avastin (bevacizumab) - July 2019
  • Aranesp (darbepoetin alfa) - May 2024
  • Enbrel (etanercept) - November 2028

Companies such as Teva Pharmaceuticals, Hospira, Sandoz and Amgen are focusing their resources ondevelopment of biosimilars. Also, vaccines are other major products in development to focus on prevention aspect rather than just treatment. For instance, 2015 marked the U.S. launch of Zarxio TM, the first biosimilar approved in this market and the EMA approval of Mosquirix, the malaria vaccine. Extensive research is currently underway to develop a dengue vaccine, which could be another breakthrough pharmaceutical product in the near future.

Conclusion

Increasing research in biotech sector, in turn would translate into higher number of biopharma products seeking FDA approvals in future. Biopharma is positioned to be a promising treatment solution that would improve treatment outcomes and serve to accelerate and help reduce cost of drug development.

Coherent Market Insights
Wound Care Biologics Market - by Product Type (Biologic Skin Substitutes, Enzyme Based Formulations, and Growth Factors), by Application (Chronic Wounds and Acute Wounds), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Home Care Settings), and by Region - Global Industry Insights, and Forecast to 2025

Published Date : Apr 2018

Wound Care Biologics Market – Experience the Power of Effective Healing Wound care biologics are bioengineered products used for non-healing wounds of the lower extremity.  Demand for wound care bi

Coherent Market Insights
Stem Cell Banking Market, by Source Type (Cord Blood and Cord Tissue), by Service Type (Collection and Transportation, Processing, Analysis and Storage), by Application (Leukemia, Diabetes, Lymphoma, Cerebral Palsy, Thalassemia and Others), and by Region - Global Trends, and Forecast to 2025

Published Date : Feb 2018

Stem Cell Banking Market – Assurance for a Lifetime Stem cells are building blocks of the immune system and blood, and they have the ability to develop into other cell types, in order to help in repairi

Coherent Market Insights
Genome Engineering Market, By Technology (CRISPR, TALEN, ZFN, and others), By Application (Cell Line Engineering, and Genetic Engineering), By End User (Biotechnology & Pharmaceutical Companies, Research Institutes, and Contract Research Organizations) and by Geography - Global Trends and Forecast to 2025

Published Date : Apr 2018

Genome Engineering Market- Insights Genome engineering is a process of insertion, deletion, modification or replacement of DNA bases in an organism. There are two types of gene therapy, Ex-Vivo Gene Therapy a

Coherent Market Insights
Global Flow Cytometry Market, by Technology (Cell based & Bead based), by Product Type (Analyzer, Sorter, & Reagent & Consumables), by Application (Research, Clinical and Industrial), by End User (Hospital, Clinical Testing Laboratories and Research laboratories), and by Region - Trends, and Forecast till 2025

Published Date : Dec 2017

Flow Cytometry – It’s not just for immunologist anymore Flow cytometry is a widely used method for analyzing the expression of cell surface and intracellular molecules. It can also characterize a

Coherent Market Insights
Biochips Market By Product Type (DNA Chips, Protein Chips, Lab-on-a-Chip, and Others), By Technology (Microfluidics and Microarray), By Application (Genomics, Proteomics, Drug Discovery & Development, and In Vitro Diagnostics) and by Geography - Global Trends and Forecast to 2025

Published Date : Apr 2018

Biochips Market - Insights Biochips are miniaturized laboratories, which can perform simultaneous biochemical reactions. On the basis of functionality, biochips are classified as DNA chips, protein chips, lab

Coherent Market Insights
Global Pharmacogenomics Market, by Technology Type (Polymerase Chain Reaction, Sequencing, Microarray, and Other Technologies), and by Application (Drug Discovery and Therapeutic Application) and by Geography - Trends and Forecast to 2025

Published Date : Nov 2017

Pharmacogenomics Market: New Innovative Solution for Diverse Medical Applications Pharmacogenomics deals with the influence of genetic variation on drug response in patients by correlating gene expression cha

Coherent Market Insights
Recombinant DNA Technology Market, by Product Type (Recombinant Protein Drugs, Vaccines, Genetically Modified Crops, Expression Systems, Cell and Gene Therapy and Gene Editing), by Application (Therapeutics, Agriculture and Research), and by Region - Global Industry Insights, and Forecast to 2025

Published Date : Apr 2018

Recombinant DNA Technology Market – Power of Genetic Engineering in Improving Lives Recombinant DNA (rDNA) technology is a novel technique which have led to the advances in a number of different fields

Coherent Market Insights
Cell Lysis Market, by Product Type (Instruments and Reagents & Kits), by Cell Type (Mammalian Cells, Microbial Cells and Insect, Yeast and Plant Cells), By End User (Academic and Research Laboratories and Pharmaceutical and Biotechnology Laboratories), and by Geography - Global Industry Insights, and Forecast to 2025

Published Date : Apr 2018

Cell Lysis Market – Insights Cell lysis is the first step of protein extraction, which is further used for different application such as enzyme engineering and protein labelling. Furthermore, cell lysis

Coherent Market Insights
Global Forensic Technologies and Services Market, By Type (DNA Profiling, Biometric/Fingerprint Analysis, Digital Forensic, Chemical Analysis), Services (Laboratory Forensic, FaaS), Geography - Insights, Opportunity Analysis, and Industry Forecast till 2024

Published Date : May 2017

Forensic Technologies and Services: Revolutionizing Crime Solving Advanced technologies in forensics science have been of substantial importance in recent years. Few examples of such advancements include enha

Coherent Market Insights
Global B-cell Maturation Antigen (BCMA) Targeted Therapies Market, by Product Type (CAR-T cell, Bispecific Antibodies, and Antibody Drug Conjugates), by Indication (Acute Lymphoblastic Leukemia, and Multiple Myeloma), and by Geography - Insights, Size, Share, Opportunity Analysis, and Industry Forecast till 2025

Published Date : Oct 2017

B-Cell Maturation Antigen (BCMA) Targeted Therapy – An innovative therapy for Multiple Myeloma Multiple myeloma (MM) refers to a clonal plasma cell malignant neoplasm that is observed in the soft, spon

Coherent Market Insights
Peptide Cancer Vaccine Market, by Pipeline Phase (Research, Preclinical, Phase-I, Phase-I/II, Phase-II, and Phase III), by Application (Colorectal Cancer, Lung Cancer, Pancreatic Cancer, Gastric Cancer, Prostate Cancer, and Breast Cancer), and by Region - Global Insights, Industry Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Peptide cancer vaccines aids to elicit and expand tumor-specific T-cells capable of controlling or eradicating tumor. This vaccine consists of one or more short or long amino acid sequences as tumor antigens, combined with vaccine adjuvant. In the recent past, results

Coherent Market Insights
Stem Cell Assay Market, By Product Type (Instruments and Reagents & Kits), By Cell Type (Adult Stem Cells and Human Embryonic Stem Cells), By Process (Cell Culture, Engineering, Differentiation, Characterization, and Others), By Application (Research, Drug Discovery & Development, and Regenerative Medicine), and By Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Stem cells are basic form of biological cells, which can differentiate into other types of cells and can produce more of the same type of stem cells. There are two types of stem cells, which include embryonic stem cells, and adult stem cells. These cells are present i

Coherent Market Insights
Lyme Disease Diagnostics Market, by Diagnostics Test (Enzyme Linked Immunosorbent Assay, Western Blot, and Others), by End User (Hospitals, Clinics, and Diagnostic Laboratories) and by Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Lyme disease occurs due to bacterium Borrelia burgdorferi (Bb) and is transmitted to humans through the bite of infected blacklegged ticks. Its general symptoms include fatigue, headache, fever and a skin rash called erythema migrans. The infection can spread to heart

Coherent Market Insights
Seasonal Influenza Vaccines Market, By Vaccine Type (Trivalent Flu Vaccines and Quadrivalent Flu Vaccines), By Virus Type (Influenza Virus Type A and Influenza Virus Type B), By Age Group (Pediatrics and Adults), By End User (Hospitals, Clinics, and Ambulatory Care Centers) and By Geography - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2018-2026

To Be Published : May 2018

Influenza is contagious respiratory disease that is caused by influenza viruses and can lead to hospitalization and even death in certain severe cases. Influenza virus infect the respiratory tract (nose, throat, and lungs) in humans. Seasonal influenza detected year-r

Coherent Market Insights
Tuberculosis Vaccine Market, by Type of Vaccine (Viral Vector Vaccine, Recombinant Protein Vaccine, Recombinant BCG Vaccine, Attenuated Vaccine, and Others) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2018-2026

To Be Published : May 2018

Tuberculosis (TB) is a highly contagious disease caused by the bacterium known as Mycobacterium tuberculosis and is mostly spread through person to person contact. It causes multisystem infection and eventually might lead to death of the infected person. Two types of

Coherent Market Insights
Anti-body Coupled T Receptor Therapy Market - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2018-2026

To Be Published : May 2018

Anti-body coupled T receptor (ACTR) therapy is kind of immunotherapy used to treat cancer in which body’s own immune response is utilized to act on cancerous cell. Anti-body coupled T receptor therapy utilizes T cells from body, engineered it to express specific

Coherent Market Insights
Human Papillomavirus (HPV) Infection Vaccines Market by Product (Gardasil, Gardasil 9, Cervarix and Other Vaccines), by End Users (Hospital, Clinics, Healthcare Centers, and Others) and by Region - Global Industry Insights, Trends, Outlook and Opportunity Analysis 2018-2025

To Be Published : May 2018

Human papillomavirus infection is most common sexually transmitted infection caused by HPV-related cancers such as cervical and genital cancer. Human papillomavirus infection vaccines are used to prevent genital wart, anal cancer, cervical cancer, and vaginal cancer.

Coherent Market Insights
Hepatitis Vaccine Market, by Indication (Hepatitis A and Hepatitis B), By Vaccine Type (Recombinant Vaccine and Inactivated Vaccine) by Distribution Channel (Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Hepatitis is an infectious disease caused due to hepatitis virus type A, B, and C, which leads to liver associated disease such as Hepatitis A, hepatitis B, hepatitis C,  liver cirrhosis, hepatocellular carcinoma, and liver failure. It may lead to death of infect

Coherent Market Insights
Gene Synthesis Market, by Product Type (Gene Library Synthesis and Custom Gene Synthesis), by Application (Solid Phase Synthesis, Chip-based DNA Synthesis, and PCR-based Enzyme Synthesis), by End User (Academic and Research Institutes, Biopharmaceutical Companies, and Contract Research Organizations) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2025

To Be Published : May 2018

Gene synthesis is chemically in vitro synthesis of double-stranded DNA molecules. It is a technology used in biotechnology and plays an important role in the field of synthetic biology. The technology has become a significant tool in various fields of recombinant DNA

Coherent Market Insights
Immune Anti-Inhibitor Market, by Product Type (Recombinant, Plasma-Derived, and Others), by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Immune inhibitors are associated with haemophilia and inhibitors are antibodies developed in haemophilia patients. Haemophilia is a hereditary bleeding disorder, which occurs due to deficiency or absence of clotting factor VIII (haemophilia A) or clotting factor IX (h

Coherent Market Insights
Low Molecular Weight Heparin Market - by Drug Type (Enoxaparin, Dalteparin, Tinzaparin, and Others), by Application (Venous Thromboembolism, Myocardial Infraction, Complicated Pregnancies, Cardioversion of Atrial Fibrillation, and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) - Global Industry Insights, Trends, Outlook, and Opportunity Analysis 2017-2025

To Be Published : May 2018

Low Molecular Weight Heparins (LMWH) are a form of pharmacological anticoagulant intervention. Low molecular weight heparin is used for prophylaxis of deep vein thrombosis and pulmonary embolism, or thrombosis occurring in a broad spectrum of clinical indications, inc

Coherent Market Insights
Diabetes Vaccine Market, by Age Group (Up to 20 Years of Age and 20 Years and above), by End User (Hospitals and Clinics) and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Diabetes is one of most prevalent chronic diseases worldwide. According to WHO (World Health Organization), diabetes was one of top three leading causes of mortality in 2012. The diabetes vaccine currently under development has significant potential in younger age gro

Coherent Market Insights
Ebola Vaccine Market, By Virus Strain (Recombinant vesicular stomatitis virus-Zaire Ebola virus, Chimpanzee Adeno virus type 3-Zaire Ebola virus, and Adeno virus serotype 26- Zaire Ebola Virus) and by Geography — Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017–2025

To Be Published : May 2018

Ebola virus disease (EVD) causes viral hemorrhagic fever. It is a life threatening disease, which is spread to humans from animals. Direct contact with body fluids of infected person is one of largest causes of spread of this infection. Symptoms of Ebola disease inclu

Coherent Market Insights
Oncology Biosimilars Market, By Cancer Type (Lung Cancer, Colorectal Cancer, Cervical Cancer, Breast Cancer, Kidney Cancer, Stomach Cancer, Brain Cancer, and Others), By Product Type (Monoclonal Antibodies, Immunomodulators, and Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies), By Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017-2025

To Be Published : May 2018

Biosimilar is a biological product that resembles a reference product and is not difference from the already approved reference product. These are relatively cheaper than branded or approved products. Several biologics for oncology have already lost their patents, and

"How Can I Help You" ?

Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.

Coherent Market Insights Benefits

  • Custom Research Solution

    Talk to our research consultant to design an exclusive report as per your research needs.

  • Customer Fulfilment

    We aim to fulfil client's research demands with tailored research solutions.

  • Quick Turnaround Time Reports

    We aim to provide research studies in quickest turnaround time and in a much cost effective manner.

  • 360-degree Approach

    We cover each industry from supply and demand side with an aim to provide a most holistic research study.

  • Assured Quality

    We strive to provide most accurate and reliable research findings in our research reports.